Center for Oncology and Blood Disorders

Houston, Texas 77030

1 studies enrolling now · 8 studies all time

What they study most

Advanced Cholangiocarcinoma, Advanced MTAP-null Solid Tumors, Bile Duct Cancer, Breast Cancer, Chordoma of Sacrum, Colon Cancer, Diffuse Large B-cell Lymphoma (DLBCL), FGFR2 Fusions, Follicular Lymphoma (FL), Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma, Gene Rearrangement, Head and Neck Cancer

Studies at this site

• A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma — Recruiting now
• A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma — Recruiting now
• Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement — Recruiting now
• A Study of Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101) — Running, not enrolling
• A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular Lymphoma — Running, not enrolling
• A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 — Completed
• A Study of NDI 1150-101 in Patients With Solid Tumors — Running, not enrolling
• Safety Study of Enoblituzumab (MGA271) in Combination With Ipilimumab in Refractory Cancer — Completed